Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00293332
Recruitment Status : Terminated (Terminated due to low subject accrual)
First Posted : February 17, 2006
Last Update Posted : February 9, 2011
National Cancer Institute (NCI)
Information provided by:
University of California, San Francisco

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2007
  Actual Study Completion Date : April 2007